Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe
Launched by UNIVERSITY OF COLORADO, DENVER · Jan 7, 2013
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
The "Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe" (SIKO Study) will consist of both an interventional and an observational component. Eight (8) primary care sites in Zimbabwe will be randomized to receive structured training on Kaposi sarcoma (KS) diagnosis and treatment. This intervention will be evaluated through the utilization of three components; the KS Standardized Evaluation (KS-SE), integration of palliative care and an algorithm-based KS management strategy at the sites. The impact of the overall intervention will be evaluated using a step-wedge randomized cluste...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects between the ages of 1 and 80,
- • Recruited from the eight (8) participating primary care sites,
- • Subjects newly identified with Kaposi sarcoma (KS) and HIV-1 infection.
- Exclusion Criteria:
- • None Noted
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Harare, , Zimbabwe
Patients applied
Trial Officials
Thomas B. Campbell, MD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials